Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

Circulation

Volumn 103, Issue 15, 2001, Pages 1961-1966

  Koh, Kwang Kon ^a   Jin, Dong Kyu ^a   Yang, Seong Hee ^a   Lee, Seon Kyu ^a   Hwang, Hee Young ^a   Kang, Moon Ho ^a   Kim, Wan ^a   Kim, Dae Sung ^a   Choi, In Suck ^a   Shin, Eak Kyun ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Cell adhesion molecules; Endothelium; Fibrinolysis; Proteins

Indexed keywords

CONJUGATED ESTROGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GESTAGEN; INTERCELLULAR ADHESION MOLECULE 1; MEDROXYPROGESTERONE ACETATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBRINOLYSIS; HOMEOSTASIS; HUMAN; HYPEREMIA; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0035901620     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.15.1961     Document Type: Article

References (35)

1. Hormone replacement therapy and incidence of acute myocardial infarction: A population-based nested case-control study
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
3. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
4. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
5. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
6. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells
7. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes
8. Effects of estrogen and vitamin E therapies on vascular function in postmenopausal women
9. The effect of estrogen and cholesterol-lowering therapies on vascular function in hypercholesterolemic postmenopausal women
10. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
11. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
12. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
13. Atherosclerosis: An inflammatory disease
14. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
15. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
16. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
17. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility
18. 2+ mobilization
19. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
20. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
21. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
22. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
23. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock
24. Circulating adhesion molecules VCAM-1, ICAM-I, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study
25. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
26. Monocyte chemoattractant protein-1 but not tumor necrosis factor-α is correlated with monocyte infiltration in mouse lipid lesions
27. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages
28. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis
29. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
30. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
31. Prospective study of exogenous hormones and risk of pulmonary embolism in women
32. Effect of postmenopausal hormones on inflammation-sensitive proteins. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
33. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C)
34. Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women
35. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause